Literature DB >> 16518521

Effect of propionylcarnitine on changes in endothelial function and plasma levels of adhesion molecules induced by acute exercise in patients with intermittent claudication.

Antonio Silvestro1, Vittorio Schiano, Roxana Bucur, Gregorio Brevetti, Francesco Scopacasa, Massimo Chiariello.   

Abstract

In patients with intermittent claudication, treadmill exercise may cause acute deterioration of endothelial function and increase in plasma concentrations of adhesion molecules. The authors evaluated the efficacy of intravenously administered propionylcarnitine (PLC)in preventing these phenomena. Thirty-six claudicants with postexercise decrease in brachial artery flow-mediated dilation (FMD)were randomized to either placebo or PLC (600 mg as a single bolus followed by 1 mg/kg/min for 60 minutes).In the 18 patients randomized to placebo, FMD markedly decreased with exercise before (from 6.8 +/-0.4% to 4.0 +/-0.4%; p < 0.001) and after treatment (from 6.5 +/-0.4% to 4.4 +/-0.5%; p < 0.001). By contrast, in the PLC group, FMD significantly decreased with exercise before treatment (from 8.0 +/-0.7% to 4.4 +/-0.4%; p < 0.001), but not after active drug administration (from 7.1 +/-0.7% to 6.0 +/-0.6%; p = 0.067). The difference between treatments was not significant (p = 0.099; ANOVA). However, in the PLC group, the authors found that the greater the exercise-induced deterioration in endothelial function before treatment, the greater the capacity of PLC to prevent a postexercise decrease in FMD (r = -0.50, p = 0.034). Accordingly, they analyzed data in the 19 patients with a baseline exercise-induced decrease in FMD >or=45% (ie, the median FMD reduction in the entire group of 36 patients), and found that the exercise-induced FMD decrease was less after PLC than after placebo (p = 0.046, ANOVA). In the same subgroup, the exercise-induced increase in plasma concentrations of soluble vascular cell adhesion molecule-1 (sVCAM-1) was significantly higher before than after treatment in patients randomized to PLC (23.4 +/-5% vs 15.3 +/-7%, p = 0.007). In conclusion, in patients with intermittent claudication suffering from a greater endothelial derangement after treadmill, PLC administration provided a protective effect against deterioration of FMD and increase of sVCAM-1 induced by exercise.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16518521     DOI: 10.1177/000331970605700203

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  7 in total

1.  Acute exhaustive rowing exercise reduces skin microvascular dilator function in young adult rowing athletes.

Authors:  Marko Stupin; Ana Stupin; Lidija Rasic; Anita Cosic; Luka Kolar; Vatroslav Seric; Helena Lenasi; Kresimir Izakovic; Ines Drenjancevic
Journal:  Eur J Appl Physiol       Date:  2017-12-21       Impact factor: 3.078

Review 2.  Inflammation and L-carnitine therapy in hemodialysis patients: a review.

Authors:  Saman Khalatbari-Soltani; Hadi Tabibi
Journal:  Clin Exp Nephrol       Date:  2014-12-02       Impact factor: 2.801

Review 3.  Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.

Authors:  Carmen Mingorance; Rosalía Rodríguez-Rodríguez; María Luisa Justo; María Alvarez de Sotomayor; María Dolores Herrera
Journal:  Vasc Health Risk Manag       Date:  2011-03-28

4.  Does L-carnitine improve endothelial function in hemodialysis patients?

Authors:  Mohammad Reza Sabri; Farnaz Fahimi; Soheila Hajialiasgar; Abbas Etminan; Sarir Nazemi; Farzaneh Salehi
Journal:  J Res Med Sci       Date:  2012-05       Impact factor: 1.852

5.  Effects of propionyl-L-carnitine on ischemia-reperfusion injury in hamster cheek pouch microcirculation.

Authors:  Dominga Lapi; Lina Sabatino; Giovanna Giuseppina Altobelli; Paolo Mondola; Vincenzo Cimini; Antonio Colantuoni
Journal:  Front Physiol       Date:  2010-10-19       Impact factor: 4.566

6.  Effects of Carnitine Administration on Carotid Intima-media Thickness and Inflammatory Factors in Patients with Polycystic Ovary Syndrome: A Randomized, Double-blind, Placebo-controlled Trial.

Authors:  Hamid Reza Talari; Zeinab Jafari Azad; Yaser Hamidian; Mansooreh Samimi; Hamid Reza Gilasi; Faraneh Ebrahimi Afshar; Vahidreza Ostadmohammadi; Zatollah Asemi
Journal:  Int J Prev Med       Date:  2019-06-07

Review 7.  Can the measurement of brachial artery flow-mediated dilation be applied to the acute exercise model?

Authors:  Jaume Padilla; Ryan A Harris; Janet P Wallace
Journal:  Cardiovasc Ultrasound       Date:  2007-11-26       Impact factor: 2.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.